JP2011012060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011012060A5 JP2011012060A5 JP2010147994A JP2010147994A JP2011012060A5 JP 2011012060 A5 JP2011012060 A5 JP 2011012060A5 JP 2010147994 A JP2010147994 A JP 2010147994A JP 2010147994 A JP2010147994 A JP 2010147994A JP 2011012060 A5 JP2011012060 A5 JP 2011012060A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antitrypsin
- alpha
- treatment
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 claims 4
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 claims 4
- 229940024142 alpha 1-antitrypsin Drugs 0.000 claims 4
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 1
- 238000010188 recombinant method Methods 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
- 239000002753 trypsin inhibitor Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200930387 | 2009-06-30 | ||
| ES200930387A ES2332645B1 (es) | 2009-06-30 | 2009-06-30 | Utilizacion de alfa-1-antitripsina para la preparacion de medicamentos para el tratamiento del sindrome de fatiga cronica. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011012060A JP2011012060A (ja) | 2011-01-20 |
| JP2011012060A5 true JP2011012060A5 (https=) | 2011-03-31 |
| JP5231490B2 JP5231490B2 (ja) | 2013-07-10 |
Family
ID=41571181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010147994A Active JP5231490B2 (ja) | 2009-06-30 | 2010-06-29 | 慢性疲労症候群の治療用の医薬の製造のための、アルファ−１−アンチトリプシンの使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9205134B2 (https=) |
| EP (1) | EP2289540B1 (https=) |
| JP (1) | JP5231490B2 (https=) |
| CN (1) | CN101934071B (https=) |
| AR (1) | AR077123A1 (https=) |
| AU (1) | AU2010202203B2 (https=) |
| BR (1) | BRPI1002087B1 (https=) |
| CA (1) | CA2706212C (https=) |
| CL (1) | CL2010000575A1 (https=) |
| ES (2) | ES2332645B1 (https=) |
| MX (1) | MX2010006125A (https=) |
| NZ (1) | NZ585890A (https=) |
| PL (1) | PL2289540T3 (https=) |
| PT (1) | PT2289540E (https=) |
| RU (1) | RU2436590C1 (https=) |
| UY (1) | UY32670A (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014014751A8 (pt) * | 2011-12-19 | 2017-07-04 | Lfb Usa Inc | composição compreendendo alfa-1-antitripsina, células epiteliais de glândula mamária, mamífero não humano transgênico, e, método para reduzir a atividade de elastase no pulmão |
| US10034921B2 (en) | 2013-02-13 | 2018-07-31 | Laboratoire Français Du Fractionnement Et Des Biotechnologies | Proteins with modified glycosylation and methods of production thereof |
| US20220160847A1 (en) * | 2020-11-20 | 2022-05-26 | Mark Egly | Method of preventing and/or treating a plurality of diseases |
| WO2023184473A1 (zh) * | 2022-04-01 | 2023-10-05 | 首创生物技术有限公司 | 肽用于治疗神经退行性疾病或改善认知功能的用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2281222A (en) * | 1941-09-27 | 1942-04-28 | American Bosch Corp | Speed regulator for internal combustion engines |
| US5753624A (en) * | 1990-04-27 | 1998-05-19 | Milkhaus Laboratory, Inc. | Materials and methods for treatment of plaquing disease |
| EP0584185B1 (en) * | 1991-05-14 | 1999-08-11 | Ernir Snorrason | Treatment of fatigue syndrome with cholinesterase inhibitors |
| WO2000051623A2 (en) | 1999-03-05 | 2000-09-08 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions |
| WO2001081343A2 (en) * | 2000-04-21 | 2001-11-01 | Pharmacia & Upjohn Company | Compounds for treating fibromyalgia and chronic fatigue syndrome |
| WO2002006837A1 (en) * | 2000-07-14 | 2002-01-24 | Matsushita Electric Industrial Co., Ltd. | Particle-labeled protein and immuno-chromatograph using the same |
| AU2003286258B2 (en) | 2002-11-20 | 2006-12-21 | Arriva-Prometic Inc. | Composition and method for treating inflammatory diseases using protease inhibitors |
| US7344882B2 (en) * | 2003-05-12 | 2008-03-18 | Bristol-Myers Squibb Company | Polynucleotides encoding variants of the TRP channel family member, LTRPC3 |
| US7850970B2 (en) * | 2003-08-26 | 2010-12-14 | The Regents Of The University Of Colorado | Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
| WO2006026837A1 (en) * | 2004-09-07 | 2006-03-16 | Patrick Englebienne | Diagnostic methods for measuring elastase activity levels |
| ES2281222B1 (es) | 2004-09-24 | 2008-06-01 | Grifols, S.A. | Utilizacion de alfa-1 antitripsina para la preparacion de medicamentos para el tratamiento de la fibromialgia. |
| EP2114141A2 (en) * | 2007-01-10 | 2009-11-11 | University of Florida | Compounds and methods for treatment of alpha-1 antitrypsin deficiency |
| MX2010003113A (es) * | 2007-09-25 | 2010-04-01 | Abbott Lab | Compuestos de octahidropentaleno como antagonistas del receptor de quimiocina. |
| HUE030205T2 (en) | 2007-11-02 | 2017-05-29 | Grifols Therapeutics Inc | A method, composition, and product for providing alpha-1-antitrypsin |
-
2009
- 2009-06-30 ES ES200930387A patent/ES2332645B1/es not_active Expired - Fee Related
-
2010
- 2010-05-20 ES ES10380071T patent/ES2392691T3/es active Active
- 2010-05-20 PT PT103800710T patent/PT2289540E/pt unknown
- 2010-05-20 EP EP10380071A patent/EP2289540B1/en active Active
- 2010-05-20 PL PL10380071T patent/PL2289540T3/pl unknown
- 2010-05-27 UY UY0001032670A patent/UY32670A/es not_active Application Discontinuation
- 2010-05-28 AU AU2010202203A patent/AU2010202203B2/en active Active
- 2010-06-02 NZ NZ585890A patent/NZ585890A/en not_active IP Right Cessation
- 2010-06-02 CL CL2010000575A patent/CL2010000575A1/es unknown
- 2010-06-03 MX MX2010006125A patent/MX2010006125A/es active IP Right Grant
- 2010-06-04 CA CA2706212A patent/CA2706212C/en active Active
- 2010-06-17 AR ARP100102142A patent/AR077123A1/es unknown
- 2010-06-24 BR BRPI1002087-0A patent/BRPI1002087B1/pt not_active IP Right Cessation
- 2010-06-24 US US12/822,764 patent/US9205134B2/en active Active
- 2010-06-29 JP JP2010147994A patent/JP5231490B2/ja active Active
- 2010-06-29 RU RU2010126653/15A patent/RU2436590C1/ru active
- 2010-06-30 CN CN2010102168418A patent/CN101934071B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013520405A5 (https=) | ||
| EP2749280A3 (en) | Combination of glycopyrronium and formoterol | |
| JP2015517983A5 (https=) | ||
| EA026667B9 (ru) | Фармацевтическая композиция для лечения вируса гепатита с | |
| JP2012092110A5 (https=) | ||
| MY159058A (en) | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agent | |
| MX2012000488A (es) | Terapia de combinacion para el tratamiento de la diabetes. | |
| WO2013021199A3 (en) | Eutectic mixture for pulmonary administration | |
| JP2015517488A5 (https=) | ||
| LT3133070T (lt) | Eligliustatas (genz 112638) kaip gliukozilceramido sintazės slopiklis, skirtas naudoti fabri arba gošė ligos gydymo būde, kur būdas apima individualios terapinės dozės priderinimą paciento p-450 metabolizmui | |
| CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
| CL2011000571A1 (es) | Uso de una combinacion de: a) un compuesto de formula (1) o una sal farmaceuticamente aceptable del mismo, b) interferon alfa y c) ribavirina para preparar un medicamento util para el tratamiento de una infeccion viral de la hepatitis c (hcv) o para aliviar uno o mas sintomas de la misma. | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| MX366906B (es) | Purificacion de iduronato-2-sulfatasa. | |
| JP2014503593A5 (https=) | ||
| CO6612185A2 (es) | Composiciones famacéuticas para el tratamiento del cáncer y otras enfermedades o transtornos | |
| UY29506A1 (es) | Nuevas formas cristalinas de bromuro de tiotropio | |
| PE20150171A1 (es) | Nueva forma de dosificacion y formulacion de abediterol | |
| JP2013533269A5 (https=) | ||
| MD4369B1 (ro) | Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei | |
| WO2013058484A3 (ko) | 인제난 타입의 디테르펜 화합물 및 이를 포함하는 바이러스 감염 질환의 치료 또는 예방용 약학적 조성물 | |
| JP2014532722A5 (https=) | ||
| JP2011012060A5 (https=) | ||
| MA34084B1 (fr) | Composition comprenant le peptide amyloïde bêta 1-6 couplé à une particule de type virus et un adjuvant | |
| CL2008000973A1 (es) | Compuestos derivados de 1-oxo-isoquinolina; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de enfermedades pulmonares obstructvas crónicas (epoc) y asma. |